The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Few and Far Between: How HIV May Be Evading Antibody Avidity
Open accessAbstract
The authors have declared that no competing interests exist. This work was conducted with support from the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (www.cavd.org) and the Grand Challenges in Global Health Initiative (www.grandchallenges.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Atomic structure of the ectodomain from HIV-1 gp41
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1997) · Nature · doi:10.1038/387426a0 · Cited by 1,622
Migueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D., Sullivan, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050567397 · Cited by 995
Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design
Saphire, E. O., Parren, P. W. H. I., Pantophlet, R., Zwick, M. B., Morris, G. M., Rudd, P. M., Dwek, R. A., Stanfield, R. L., Burton, D. R., & Wilson, I. A. (2001) · Science · doi:10.1126/science.1061692 · Cited by 942
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Scheid, J. F., Mouquet, H., Feldhahn, N., Seaman, M. S., Velinzon, K., Pietzsch, J., Ott, R. G., Anthony, R. M., Zebroski, H., Hurley, A., et al. (2009) · Nature · doi:10.1038/nature07930 · Cited by 867
Vaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829 · cited 1×
“. Nevertheless, these viruses and many others and/or the vaccines that have been developed against them elicit potent neutralizing antibody responses that significantly contribute to their clearance or provide sterilizing immunity”
BackgroundMolecular architecture of native HIV-1 gp120 trimers
Liu, J., Bartesaghi, A., Borgnia, M. J., Sapiro, G., & Subramaniam, S. (2008) · Nature · doi:10.1038/nature07159 · Cited by 816
Distribution and three-dimensional structure of AIDS virus envelope spikes
Zhu, P., Liu, J., Bess, J., Chertova, E., Lifson, J. D., Grisé, H., Ofek, G. A., Taylor, K. A., & Roux, K. H. (2006) · Nature · doi:10.1038/nature04817 · Cited by 780
Structural definition of a conserved neutralization epitope on HIV-1 gp120
Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770
Starcich, B. R., Hahn, B. H., Shaw, G. M., McNeely, P. D., Modrow, S., Wolf, H., Parks, E. S., Parks, W. P., Josephs, S. F., Gallo, R. C., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90778-6 · Cited by 767
Structure of a V3-Containing HIV-1 gp120 Core
Huang, C.-C., Tang, M., Zhang, M.-Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber, B., Sodroski, J., Wilson, I. A., et al. (2005) · Science · doi:10.1126/science.1118398 · Cited by 731
Scanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Tomaras, G. D., Yates, N. L., Liu, P., Qin, L., Fouda, G. G., Chavez, L. L., Decamp, A. C., Parks, R. J., Ashley, V. C., Lucas, J. T., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01708-08 · Cited by 631
Cellular immune responses to HIV
McMichael, A. J., & Rowland-Jones, S. L. (2001) · Nature · doi:10.1038/35073658 · Cited by 616
Structure of an unliganded simian immunodeficiency virus gp120 core
Chen, B., Vogan, E. M., Gong, H., Skehel, J. J., Wiley, D. C., & Harrison, S. C. (2005) · Nature · doi:10.1038/nature03327 · Cited by 520
Hessell, A. J., Rakasz, E. G., Poignard, P., Hangartner, L., Landucci, G., Forthal, D. N., Koff, W. C., Watkins, D. I., & Burton, D. R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000433 · Cited by 497
Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., & Kwong, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10724-10737.2004 · Cited by 490
GP120: Target for Neutralizing HIV-1 Antibodies
Pantophlet, R., & Burton, D. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090557 · Cited by 445
Skehel, J. J., Stevens, D. J., Daniels, R. S., Douglas, A. R., Knossow, M., Wilson, I. A., & Wiley, D. C. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.6.1779 · Cited by 444
Pantaleo, G., & Koup, R. A. (2004) · Nature Medicine · doi:10.1038/nm0804-806 · Cited by 444
Zhu, P., Chertova, E., Bess, J., Lifson, J. D., Arthur, L. O., Liu, J., Taylor, K. A., & Roux, K. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2634931100 · Cited by 431
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
Stamatatos, L., Morris, L., Burton, D. R., & Mascola, J. R. (2009) · Nature Medicine · doi:10.1038/nm.1949 · Cited by 430
Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4
Huang, C.-C., Lam, S. N., Acharya, P., Tang, M., Xiang, S.-H., Hussan, S. S.-U., Stanfield, R. L., Robinson, J., Sodroski, J., Wilson, I. A., et al. (2007) · Science · doi:10.1126/science.1145373 · Cited by 416
Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates
Kwong, P. D., Wyatt, R., Majeed, S., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (2000) · Structure · doi:10.1016/s0969-2126(00)00547-5 · Cited by 390
Labrijn, A. F., Poignard, P., Raja, A., Zwick, M. B., Delgado, K., Franti, M., Binley, J., Vivona, V., Grundner, C., Huang, C.-C., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10557-10565.2003 · Cited by 357
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
Karlsson Hedestam, G. B., Fouchier, R. A. M., Phogat, S., Burton, D. R., Sodroski, J., & Wyatt, R. T. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1819 · Cited by 339
Layne, S. P., Merges, M. J., Dembo, M., Spouge, J. L., Conley, S. R., Moore, J. P., Raina, J. L., Renz, H., Gelderblom, H. R., & Narat, P. L. (1992) · Virology · doi:10.1016/0042-6822(92)90593-e · Cited by 332
Yu, X., Yuan, X., Matsuda, Z., Lee, T. H., & Essex, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4966-4971.1992 · Cited by 319
Moore, J. P., & Sodroski, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1863-1872.1996 · Cited by 304
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
Chen, L., Do Kwon, Y., Zhou, T., Wu, X., O’Dell, S., Cavacini, L., Hessell, A. J., Pancera, M., Tang, M., Xu, L., et al. (2009) · Science · doi:10.1126/science.1175868 · Cited by 300
Antibody vs. HIV in a clash of evolutionary titans
Burton, D. R., Stanfield, R. L., & Wilson, I. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505126102 · Cited by 299
Chertova, E., Bess, Crise, B. J., Sowder, R. C., Schaden, T. M., Hilburn, J. M., Hoxie, J. A., Benveniste, R. E., Lifson, J. D., Henderson, L. E., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5315-5325.2002 · Cited by 290
Xiao, X., Chen, W., Feng, Y., Zhu, Z., Prabakaran, P., Wang, Y., Zhang, M.-Y., Longo, N. S., & Dimitrov, D. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.029 · Cited by 260
Cryo-Electron Tomographic Structure of an Immunodeficiency Virus Envelope Complex In Situ
Zanetti, G., Briggs, J. A. G., Grünewald, K., Sattentau, Q. J., & Fuller, S. D. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020083 · Cited by 232
Rossmann, M. G. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63732-9 · Cited by 226
The influence of virus structure on antibody responses and virus serotype formation
Bachmann, M. F., & Zinkernagel, R. M. (1996) · Immunology Today · doi:10.1016/s0167-5699(96)10066-9 · Cited by 204
Wu, H., Pfarr, D. S., Tang, Y., An, L.-L., Patel, N. K., Watkins, J. D., Huse, W. D., Kiener, P. A., & Young, J. F. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.04.049 · Cited by 204
Electron Tomography of the Contact between T Cells and SIV/HIV-1: Implications for Viral Entry
Sougrat, R., Bartesaghi, A., Lifson, J. D., Bennett, A. E., Bess, J. W., Zabransky, D. J., & Subramaniam, S. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030063 · Cited by 193
Stoichiometry of Envelope Glycoprotein Trimers in the Entry of Human Immunodeficiency Virus Type 1
Yang, X., Kurteva, S., Ren, X., Lee, S., & Sodroski, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12132-12147.2005 · Cited by 169
Klein, J. S., Gnanapragasam, P. N. P., Galimidi, R. P., Foglesong, C. P., West, A. P., & Björkman, P. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811427106 · Cited by 163
Self-citationHIV-1 and influenza antibodies: seeing antigens in new ways
Kwong, P. D., & Wilson, I. A. (2009) · Nature Immunology · doi:10.1038/ni.1746 · Cited by 130
Structural basis for HIV-1 neutralization by a gp41 fusion intermediate–directed antibody
Luftig, M. A., Mattu, M., Giovine, P. D., Geleziunas, R., Hrin, R. C., Barbato, G., Bianchi, E., Miller, M. D., Pessi, A., & Carfı́, A. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1127 · Cited by 129
Smith, T. J., Olson, N. H., Cheng, R. H., Chase, E. S., & Baker, T. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7015 · Cited by 127
Neutralization of poliovirus by a monoclonal antibody: Kinetics and stoichiometry
Icenogle, J. P., Shiwen, H., Duke, G. M., Gilbert, S. A., Rueckert, R. R., & Anderegg, J. W. (1983) · Virology · doi:10.1016/0042-6822(83)90154-x · Cited by 120
Estimating the Stoichiometry of Human Immunodeficiency Virus Entry
Magnus, C., Rusert, P., Bonhoeffer, S., Trkola, A., & Regoes, R. R. (2008) · Journal of Virology · doi:10.1128/jvi.01764-08 · Cited by 104
Wolbank, S., Kunert, R., Stiegler, G. M., & Katinger, H. W. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4095-4103.2003 · Cited by 100
Wyatt, R. T., Desjardin, E., Olshevsky, U., Nixon, C., Binley, J. Μ., Olshevsky, V., & Sodroski, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9722-9731.1997 · Cited by 97
Diskin, R., Marcovecchio, P., & Björkman, P. J. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1796 · Cited by 91
Pantophlet, R. A., Wilson, I. A., & Burton, D. R. (2004) · Protein Engineering Design and Selection · doi:10.1093/protein/gzh085 · Cited by 57
McInerney, T. L., McLain, L., Armstrong, S. J., & Dimmock, N. J. (1997) · Virology · doi:10.1006/viro.1997.8547 · Cited by 57
West, A. P., Galimidi, R. P., Foglesong, C. P., Gnanapragasam, P. N. P., Huey‐Tubman, K. E., Klein, J. S., Suzuki, M. D., Tiangco, N. E., Vielmetter, J., & Björkman, P. J. (2008) · Journal of Virology · doi:10.1128/jvi.01564-08 · Cited by 52
Self-citationEdwards, M. J., & Dimmock, N. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.21.10208-10218.2001 · Cited by 44
Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization
Crooks, E. T., Jiang, P., Franti, M., Wong, S., Zwick, M. B., Hoxie, J. A., Robinson, J. E., Moore, P. L., & Binley, J. Μ. (2008) · Virology · doi:10.1016/j.virol.2008.04.045 · Cited by 41
Bennett, A. E., Liu, J., Ryk, D. V., Bliss, D., Arthos, J. A., Henderson, R. M., & Subramaniam, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702025200 · Cited by 40
HIV Vaccine Trial Results — An Opening for Further Research
Dolin, R. (2009) · New England Journal of Medicine · doi:10.1056/nejme0909972 · Cited by 34
A dynamical study of antibody–antigen encounter reactions
Bongini, L., Fanelli, D., Piazza, F., Rios, P. D. L., Sanner, M. F., & Skoglund, U. (2007) · Physical Biology · doi:10.1088/1478-3975/4/3/004 · Cited by 27
Bhatia, A. K., Kaushik, R., Campbell, N., Pontow, S. E., & Ratner, L. (2008) · Virology · doi:10.1016/j.virol.2008.10.047 · Cited by 24
Cited by
Barnes, C. O., West, A. P., Huey-Tubman, K. E., Hoffmann, M. A. G., Sharaf, N. G., Hoffman, P. R., Koranda, N., Gristick, H. B., Gaebler, C., Muecksch, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.025 · Cited by 795
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
Pancera, M., Zhou, T., Druz, A., Georgiev, I. S., Soto, C., Gorman, J., Huang, J., Acharya, P., Chuang, G.-Y., Ofek, G., et al. (2014) · Nature · doi:10.1038/nature13808 · Cited by 740
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R. L., Julien, J.-P., Ramos, A., Crispin, M., et al. (2011) · Science · doi:10.1126/science.1213256 · Cited by 694
Antibodies in HIV-1 Vaccine Development and Therapy
Klein, F., Mouquet, H., Dosenovic, P., Scheid, J. F., Scharf, L., & Nussenzweig, M. C. (2013) · Science · doi:10.1126/science.1241144 · Cited by 457
Phenotypic properties of transmitted founder HIV-1
Parrish, N. F., Gao, F., Li, H., Giorgi, E. E., Barbian, H. J., Parrish, E. H., Zajic, L., Iyer, S. S., Decker, J. M., Kumar, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304288110 · Cited by 422
Self-citation
Metadata
- Authors
- Klein, J. S., & Bjorkman, P. J.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-05-27
- Volume
- 6
- Issue
- 5
- Pages
- e1000908
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2006712680
- Cited by
- 271
- References
- 63
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.